RedHill Biopharma (RDHL) Interest Coverage Ratio: 2012-2023

Historic Interest Coverage Ratio for RedHill Biopharma (RDHL) over the last 11 years, with Jun 2023 value amounting to 27.91.

  • RedHill Biopharma's Interest Coverage Ratio rose 377.26% to 27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was -1.20, marking a year-over-year increase of 87.34%. This contributed to the annual value of -7.11 for FY2024, which is 640.43% down from last year.
  • RedHill Biopharma's Interest Coverage Ratio amounted to 27.91 in Q2 2023, which was up 140.40% from -69.07 recorded in Q1 2023.
  • RedHill Biopharma's 5-year Interest Coverage Ratio high stood at 167.30 for Q2 2019, and its period low was -69.07 during Q1 2023.
  • Moreover, its 3-year median value for Interest Coverage Ratio was 2.02 (2022), whereas its average is -10.17.
  • Per our database at Business Quant, RedHill Biopharma's Interest Coverage Ratio skyrocketed by 2,905.64% in 2019 and then tumbled by 1,723.72% in 2023.
  • Quarterly analysis of 5 years shows RedHill Biopharma's Interest Coverage Ratio stood at 62.91 in 2019, then plummeted by 84.65% to 9.66 in 2020, then slumped by 497.74% to -38.41 in 2021, then grew by 20.52% to -30.53 in 2022, then spiked by 377.26% to 27.91 in 2023.
  • Its Interest Coverage Ratio stands at 27.91 for Q2 2023, versus -69.07 for Q1 2023 and -30.53 for Q4 2022.